1376 Results

People

  1. Hellmann
    Hellmann
  2. Motzer
    Motzer
  3. Wolchok
    Wolchok
  4. Hyman
    Hyman
  5. Drilon
    Drilon
  6. Rosenberg
    Rosenberg
  7. Solit
    Solit
  8. Robson
    Robson
  9. Berger
    Berger
  10. Postow
    Postow

Groups

  1. Department of Medicine (1376)
  2. Solid Tumor Oncology Division (1376)
  3. Genitourinary Oncology Service (368)
  4. GSK Faculty (363)
  5. Gastrointestinal Oncology Service (290)
  6. Survivorship Research (279)
  7. Thoracic Oncology (251)
  8. Breast Medicine Service (225)
  9. Population Sciences Research Program (217)
  10. Sloan Kettering Institute Postdocs (215)
  1. "Solid Tumor Oncology Division"
  2. "2018"
Formats
  1. Meeting Abstract (710)
  2. Journal Article (653)
  3. Book Section (10)
  4. Conference Paper (2)
  5. Correspondence (1)
Groups
  1. Department of Medicine (1376)
  2. Solid Tumor Oncology Division (1376)
  3. Genitourinary Oncology Service (368)
  4. GSK Faculty (363)
  5. Gastrointestinal Oncology Service (290)
  6. Survivorship Research (279)

More Groups

People
  1. Matthew Hellmann (78)
  2. Jedd Wolchok (74)
  3. Robert Motzer (71)
  4. David Hyman (57)
  5. Alexander Drilon (55)
  6. David Solit (55)

More People

Years
  1. 2018 (1376)
Publications
  1. Journal of Clinical Oncology (372)
  2. Annals of Oncology (118)
  3. Cancer Research (93)
  4. Journal of Thoracic Oncology (53)
  5. Clinical Cancer Research (40)
  6. Journal for ImmunoTherapy of Cancer (26)

More Publications

Publishers
  1. American Society of Clinical Oncology (401)
  2. American Association for Cancer Research (158)
  3. Elsevier Inc. (147)
  4. Oxford University Press (131)
  5. Nature Publishing Group (55)
  6. Springer (55)

More Publishers

Results (1376)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Weighing the risks and benefits of neoadjuvant therapy in resectable pancreatic cancer: Neoadjuvant therapy should not be used as part of standard clinical practice
    Journal Article

    Elarre, P. S.; Yu, K. H.
    Oncology (Norwalk) (2018)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
    Journal Article

    Chung, D. J.; Carvajal, R. D.; Postow, M. A.; Sharma, S.; Pronschinske, K. B.; Shyer, J. A.; Singh-Kandah, S.; Dickson, M. A.; D'Angelo, S. P.; Wolchok, J. D.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Clonal evolution of uveal melanoma metastases
    Meeting Abstract

    Yang, J.; Geiger, H. M.; Zhao, J.; Chen, J. C.; Arora, K.; Shah, M.; Fabius, A.; Cavatore, M.; Kandoth, C.; Merghoub, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT)
    Meeting Abstract

    Tap, W. D.; Gelderblom, H.; Stacchiotti, S.; Palmerini, E.; Ferrari, S.; Desai, J.; Bauer, S.; Blay, J. Y.; Alcindor, T.; Ganjoo, K. N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • ICONIC: Biologic and clinical activity of first in class ICOS agonist antibody JTX-2011+/- nivolumab (nivo) in patients (pts) with advanced cancers
    Meeting Abstract

    Yap, T. A.; Burris, H. A.; Kummar, S.; Falchook, G. S.; Pachynski, R. K.; LoRusso, P.; Tykodi, S. S.; Gibney, G. T.; Gainor, J. F.; Rahma, O. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Treatment outcomes of cutaneous adverse events to immune checkpoint inhibitors
    Meeting Abstract

    Wu, J.; Freites-Martinez, A.; Hellmann, M. D.; Rosenberg, J. E.; Motzer, R. J.; Chapman, P. B.; Rizvi, N. A.; Geskin, L. J.; Reed, V. A.; Dusza, S. W.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy
    Meeting Abstract

    Yaeger, R.; Hersch, J.; Bates, D.; Paroder, V.; Chou, J. F.; Tang, L. H.; Gollub, M. J.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG Z5041 trial (Alliance)
    Meeting Abstract

    Wei, A. C. C.; Ou, F. S.; Shi, Q.; O'Reilly, E. M.; Meyerhardt, J. A.; Wolff, R. A.; Kindler, H. L.; Evans, D. B.; Deshpande, V.; Misdraji, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save